76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Borregaard ASA
Open
200 1.32
Overview
Share price change
24h
Min
196.8
Max
199.6
Income | 122M 251M |
|---|---|
Sales | 292M 2B |
P/E Sector Avg | 22.782 44.202 |
EPS | 2.52 |
Dividend yield | 2.14 |
Profit margin | 12.328 |
Employees | 1,174 |
EBITDA | 505M |
Dividend yield Sector Avg | 2.14% 6.03% |
|---|---|
Next Earnings | 16 Jul 2025 |
Market Cap | 454M 20B |
|---|---|
Previous open | 198.68 |
Previous close | 200 |
Borregaard ASA Chart
Past performance is not a reliable indicator of future results.
Related News
Borregaard ASA Forecast
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Borregaard ASA
Borregaard ASA engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers for various applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry. The BioMaterials segment offers specialty cellulose for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products; and cellulose fibrils for industrial applications. The Fine Chemicals segment provides fine chemical intermediates for contrast agents; and advanced bioethanol products. Borregaard ASA was incorporated in 2012 and is headquartered in Sarpsborg, Norway.